Anna Maria Trotta
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(IT)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Chemokine receptors and signaling, Renal cell carcinoma treatment, Immunotherapy and Immune Responses, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis(2015)211 cited
- → Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation(2017)177 cited
- → CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment(2021)93 cited
- → Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients(2014)92 cited
- → Chromosome abnormalities investigated by non‐invasive prenatal testing account for approximately 50% of fetal unbalances associated with relevant clinical phenotypes(2010)91 cited
- → Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi(2006)78 cited
- → Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy(2016)76 cited
- → Regulatory T cells, interleukin ( IL )‐6, IL ‐8, V ascular endothelial growth factor ( VEGF ), CXC L10, CXC L11, epidermal growth factor ( EGF ) and hepatocyte growth factor ( HGF ) as surrogate markers of host immunity in patients with renal cell carcinoma(2013)66 cited
- → Gel-embedded niosomes: Preparation, characterization and release studies of a new system for topical drug delivery(2014)65 cited
- → Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial(2016)64 cited